Evidence map›Paper›PMID 42064003›Full record

ReviewBJR artificial intelligence2025

Artificial intelligence-powered personalized patient dosimetry in CT.

John Damilakis

Abstract readReview
In one paragraph

Review in BJR artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

John DamilakisDepartment of Medical Physics, School of Medicine, University of Crete, 71003 Iraklion, Crete, Greece.ORCID https://orcid.org/0009-0001-1650-8955

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advanced X-ray imaging techniques have increased the importance of patient dosimetry, requiring better dose assessment methods and improved dose management strategies to optimize imaging protocols, resulting in diagnostic information obtained with the lowest possible dose to the patient. This review explores the potential of artificial intelligence (AI) in CT dosimetry. Using machine learning models, trained with extensive data from personalized Monte Carlo dosimetry, AI significantly enhances the dosimetry process by providing accurate, rapid dose assessments. It automates organ segmentation from CT images, a critical and traditionally time-consuming step, enabling precise estimation of organ doses. AI's ability to predict dose distributions with high accuracy facilitates the seamless integration of personalized dosimetry into clinical workflows, promising improved patient safety and optimized radiation dose management. Additionally, AI-driven approaches offer substantial advancements over conventional methodologies, which often face challenges such as prolonged computation times and labour-intensive manual processes. Despite these advancements, challenges hinder the widespread adoption of AI in CT dosimetry. These include potential biases in training data and the need for robust validation to ensure accuracy across diverse patient populations and imaging conditions. Addressing these challenges is essential for realizing the full potential of AI-powered dosimetry in clinical practice.

Indexed as

artificial intelligenceconvolutional neural networksdeep learningdeep neural networksdosimetrymachine learningradiationX-ray imaging

Identifiers

PMID42064003
PMCPMC13045712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.